Effects of Denosumab on Bone Microarchitecture After Total Knee Arthroplasty

NCT05559268 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Denosumab 60 MG/ML Injectable Solution [Prolia]
DRUG: Placebo

Sponsor

The Affiliated Hospital of Qingdao University